Five‐year maintenance of clinical response and health‐related quality of life improvements in patients with moderate‐to‐severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2 *
暂无分享,去创建一个
A. Armstrong | C. Griffiths | K. Reich | P. Foley | K. Gordon | C. Han | Y. You | B. Strober | Y. K. Shen | Y. W. Yang | M. Miller | M. Miller | Y. Shen | Y.K. Shen | K.B. Gordon | A. Armstrong | Y. Yang | C. Griffiths